Cross-Linking Antisense Oligodeoxyribonucleotides with a Photoresponsive α-Chloroaldehyde Moiety for RNA Point
Yuta Sugihara1, Yuki Nakata1, Asako Yamayoshi2,3
1Department of Biomolecular Engineering, Graduate School of Science and Technology, Kyoto Institute of Technology , Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.
Abstract:
Because point mutations in GTPase-coding genes have been reported to be responsible for the transformation of cells, anticancer reagents that react effectively and sequence selectively with target RNAs having a point mutation are highly desired. In this study, we developed novel photo-cross-linking oligodeoxyribonucleotides ((pro)PCA-ODNs) that had a caged α-chloroaldehyde group conjugated to a 2-methylpropanediyl backbone ((pro)PCA) in the middle of the strand. A kinetic study of the deprotection reaction of (pro)PCA-ODN revealed that the bis(2-nitrobenzyl)acetal group was completely deprotected within 1 min. Photo-cross-linking studies of (pro)PCA-ODNs with complementary oligoribonucleotides (ORNs) revealed that (pro)PCA-ODNs reacts efficiently and selectively with the target ORNs that have an adenosine or cytidine residue at a frontal position of the (pro)PCA residue without adverse effects of bases adjacent to the mutation site.
Insights
Researchers developed novel photo-cross-linking oligodeoxyribonucleotides ((pro)PCA-ODNs) for targeted RNA mutation detection. These reagents efficiently and selectively bind to specific RNA sequences, offering potential for new anticancer therapies.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Oligonucleotide Therapeutics
Background:
- Point mutations in GTPase-coding genes are implicated in cellular transformation.
- Development of targeted anticancer reagents for specific RNA mutations is crucial.
- Need for sequence-selective agents that can identify and react with mutated RNA.
Purpose of the Study:
- To develop novel photo-cross-linking oligodeoxyribonucleotides ((pro)PCA-ODNs).
- To investigate the reactivity and selectivity of these ODNs with target RNAs.
- To assess the potential of (pro)PCA-ODNs as anticancer reagents.
Main Methods:
- Synthesis of (pro)PCA-ODNs with a caged α-chloroaldehyde group on a 2-methylpropanediyl backbone.
- Kinetic study to determine the deprotection rate of the caged group.
- Photo-cross-linking experiments with complementary oligoribonucleotides (ORNs).
Main Results:
- The bis(2-nitrobenzyl)acetal group in (pro)PCA-ODNs showed complete deprotection within 1 minute.
- (pro)PCA-ODNs demonstrated efficient and sequence-selective photo-cross-linking with target ORNs.
- Reactivity was observed with ORNs containing adenosine or cytidine at the position adjacent to the mutation site, without affecting nearby bases.
Conclusions:
- Novel (pro)PCA-ODNs are effective photo-cross-linking agents for targeting specific RNA mutations.
- These ODNs exhibit high selectivity and efficiency in reacting with mutated RNA sequences.
- The developed technology shows promise for the development of sequence-selective anticancer reagents.
More Related Videos
16:42Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides
Published on: November 24, 2010
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Editing
RNA Stability
RNA Splicing
